Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

14. Oktober 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 2857


	Artikel 1 - 20 / 57128

	Clinical utility impact of DNA-based cytology using droplet digital methylation-specific PCR in gastric cancer. Gastric Cancer Harada H, Soeno T, Ooki A, Naito K, Minoura H, Okuno K, Fujita S, Sakuraya M, Higuchi T, Kumagai K, Naitoh T, Kumamoto Y, Hiki N, Yamashita K. PMID: 41082104 [PubMed - as supplied by publisher]
	Emerging roles of Midnolin in Cancer, Parkinson's Disease, and Metabolic dysfunction. Mol Biol Rep Kalyan M, Singh PK, Verma A. PMID: 41082056 [PubMed - indexed for MEDLINE]
	Impact of baseline hypoalbuminemia on peripheral edema induced by gemcitabine and nab-paclitaxel for pancreatic cancer treatment. Support Care Cancer Saito Y, Takekuma Y, Komatsu Y, Sugawara M. PMID: 41082007 [PubMed - indexed for MEDLINE]
	Comparative analysis of deep learning and radiomics models in predicting hepatocellular carcinoma differentiation via ultrasound. Front Med (Lausanne) Xu L, Huang Y, Fu H, Yu J, Lu B, Zheng Y, Qian J, Qian H. PMID: 41080942 [PubMed]
	Dendritic cell-related gene signature in pancreatic cancer stratifies patient subtypes and implicates a KCTD14-TNF signaling axis. Front Immunol Liang Y, Gu Y, Zhang Z, Zhong D, Yan H, Su Y, Chen Y, Wang F, Leng Z, Huang X. PMID: 41080575 [PubMed - indexed for MEDLINE]
	Neurodegeneration rewires the tumor microenvironment via the neuro-immune-cancer axis. iScience Bautista J, Coral-Riofrio EC, Suárez Urresta S, Palacios-Zavala D, Echeverría CE, Araujo-Abad S, López-Cortés A. PMID: 41079621 [PubMed]
	First-line treatment with chemotherapy, surufatinib (an angio-immuno kinase inhibitor), and camrelizumab (an anti-PD-1 antibody) for locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II randomized study. Signal Transduct Target Ther Jia R, Si HY, Fan MJ, Zhang N, Deng GC, Liu FF, Han L, Gou MM, Tan ZL, Zhang X, Wang YR, Shi Y, Zhang YY, Jia YS, Wang YQ, Han QL, Wang ZK, Dai GH. PMID: 41077611 [PubMed - indexed for MEDLINE]
	Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma: A multicenter study. Hepatobiliary Pancreat Dis Int Cheng Y, Wang JY, Lu Y, Xia YX, Zhao H, Wang Q, Zhu XL, Zu QQ, Li HK, Chen Z, Li XC, China Liver Cancer Study Group Young Investigators (CLEAP). PMID: 41077497 [PubMed - as supplied by publisher]
	The Role of the Microbiome in Pancreas Cancer: The Evolving Influence of the Fungal Mycobiome. Surg Clin North Am Awad D, Daley D. PMID: 41077432 [PubMed - indexed for MEDLINE]
	Intratumoral Heterogeneity of Ki67 Index and Its Impact on the Diagnosis and Prognostication of Pancreatic Neuroendocrine Tumors: Hot-Spot Count Differs Significantly from Random-Area Count. Endocr Pathol Eren OC, Ohike N, Tuncel D, Bagci P, Balci S, Adsay DE, Esmer R, Saka B, Pehlivanoglu B, Xue Y, Sarmiento J, Maithel SK, Kooby DA, Krasinskas A, Reid MD, Basturk O, Adsay V. PMID: 41076497 [PubMed - indexed for MEDLINE]
	A rebuttal to: A letter to editor entitled: "A panel (CA19-9, CEA and PIVKA-II) of serum markers for pancreatic cancer diagnosis". Clin Biochem Wang M, Cao D. PMID: 41076180 [PubMed - as supplied by publisher]
	Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International Pancreatic Cancer Early Detection (PRECEDE) Consortium. JCO Precis Oncol Manam A, Everett JN, Haraldsdottir S, Hart PA, Kaul V, Klute K, Schrader KA, Sussman DA, Katona BW, PRECEDE Consortium. PMID: 41075309 [PubMed - indexed for MEDLINE]
	Methylation profiling: a diagnostic tool for the diagnosis of Merkel cell carcinoma of the lymph node without detectable skin primary tumor. Virchows Arch Chantreau PL, Sohier P, Samimi M, Tallegas M, Tallet A, Guyetant S, Goeppert B, Al-Hussaini M, Toberer F, Giese N, Roessler S, von Deimling A, Kervarrec T. PMID: 41073539 [PubMed - as supplied by publisher]
	Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial. Cancer Cell Bai X, Li X, Chen Y, Qiao G, Zhang Q, Ma T, Gao S, Zhang M, Shen Y, Wu J, Yu J, Que R, Zhang X, Sun K, Xiao W, Jiang T, Liang T. PMID: 41072417 [PubMed - as supplied by publisher]
	Prognostic Impact and Predictive Model for Early Non-curative Recurrence After Liver Resection for Hepatocellular Carcinoma: a Retrospective Cohort Study. Int J Surg Shibamoto J, Moriguchi M, Notsu A, Mori K, Ashida R, Ohgi K, Otsuka S, Kato Y, Dei H, Uesaka K, Sugiura T. PMID: 41071942 [PubMed - as supplied by publisher]
	Alantolactone: structural enhancements and therapeutic insights for cancer and inflammation. Nat Prod Res Kayumov M, Sobirova FA, Khasanov O, Mukhamedov N, Asrorov AM, Mirzaakhmedov S. PMID: 41071914 [PubMed - as supplied by publisher]
	From open to robotic distal pancreatectomy: the learning curve and mastering benchmark outcomes in a Scandinavian high volume center. Langenbecks Arch Surg Krohn PS, Kiim KS, Tschuor C, Fukumori D, Burgdorf SK. PMID: 41071259 [PubMed - indexed for MEDLINE]
	Responsive nanomedicine strategies achieve pancreatic cancer precise theranostics. Bioact Mater Li F, Tang Z, Zheng Y, Jiang T, Deng L, Dai W, Zhao Y, Zheng N, Liu S, Fan Y, Lu S, Chen Y, Liu G, Zhang Y, Xiong Y. PMID: 41069763 [PubMed]
	Assessment of barriers to pancreatic cancer surveillance in high-risk individuals. J Genet Couns Snyder GG, Clay D, Karley S, Pipito S, Mueller R, Bradbury A, Maxwell K, Nathanson KL, Rohanizadegan M, Shah P, Domchek SM, Long JM, Katona BW. PMID: 41069182 [PubMed - indexed for MEDLINE]
	Late-stage hepatoid adenocarcinoma of the pancreatic head with a long survival after surgery: a case report. J Med Case Rep Yuan XY, He ZW, Danzeng A, Ciren P, Kuang D, Yang ZH, Jiang XW, Guo L, Zhang BH. PMID: 41068983 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 57128

Seite 1 von 2857



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung